National Institute of Health
A PhD graduate of Rockefeller University, Jef Boeke is a professor and director at the NYU Langone Medical Center, where he oversees the Institute for Systems Genetics. Jef Boeke is also the founder and a scientific advisory board member of CDI Labs, Inc, which together with Johns Hopkins University School of Medicine received a major grant from the National Institute of Health (NIH) to isolate, develop and characterize human transcription-specific monoclonal antibodies.
With roots reaching back to 1887, when the Marine Hospital Service launched what would become the United States Public Health Service, the National Institute of Health is designed to address the most pressing research needs of the day. Comprised of 27 centers and institutes, the NIH oversees 10 different medical research initiatives that focus funding and support on areas including women in biomedical careers and environmental influences on children’s health, among others. Throughout its history, the NIH has provided funding for hundreds of scientists, including the recipients of 87 Nobel Prizes.
In 2015 alone, the National Institute of Health awarded more than $20 billion to universities and researchers across the world. Available for career development purposes, research projects, and other programs, the NIH grant process takes approximately 10 months to complete. After submitting an application through Grants.gov, the organization assigns it to the relevant NIH institute and review group. From the third through eighth months of the process, the application is assigned an impact score after two levels of review. Finally, approved applications go through a grant negotiation period and the applicants are notified of the outcomes.
A founder of biotechnology company CDI Labs, Jef Boeke serves as a professor and director with the NYU Langone Medical Center. Jef Boeke is also a fellow of the American Academy of Arts and Sciences, an organization that supports a range of independent research and public policy initiatives.
Released by the American Academy in 2014, Public Trust in Vaccines: Defining a Research Agenda is the result of a workshop that was chaired by authoritative professionals from the University of Washington, the Harvard School of Public Health, and the Massachusetts Institute of Technology. This workshop worked to mitigate the erosion of public trust in childhood vaccines by determining the research measures that are necessary to better understand how the general public forms misperceptions about these vaccines.
The initiative concluded that public health leaders must make immunization education a top priority by developing evidence-based actions to promote the optimal use of vaccines. Public Trust in Vaccines recommends that government agencies and private foundations support cross-disciplinary research on the subject of vaccine decision-making, while continually evaluating the effectiveness of existing health communication strategies.
Cultural Programs of the National Academy of Sciences
Experienced educator and geneticist Dr. Jef Boeke works as a professor at NYU School of Medicine and leads as the founding director of the Institute for Systems Genetics at the NYU Langone Medical Center in New York City. In recognition of his accomplishments, Dr. Jef Boeke has earned induction into three national academies, including the prestigious National Academy of Sciences.
In addition to overseeing activities aimed at providing the nation with independent, objective guidance on scientific and technological matters, the National Academy of Sciences (NAS) conducts its diverse Cultural Programs initiative in an effort to highlight the relationship between culture and science. Through permanent and rotating art exhibits, theatrical readings, lectures, and other public events, Cultural Programs of the National Academy of Sciences (CPNAS) showcases interdisciplinary projects and helps communicate the history of science to NAS visitors.
Currently, CPNAS is showing several exhibitions, including Sentient Chamber, an interactive architectural installation that reacts to the presence of visitors through effects of light and sound. Created with the help of architects, engineers, scientists, and artists, the interdisciplinary exhibit opened on November 2, 2015, and will be on display at the NAS building in Washington, DC, until May 31, 2016.
As with other CPNAS exhibitions and events, Sentient Chamber is open to the public free of charge. For more information about it and/or CPNAS, visit www.cpnas.org.